Community for Open Antimicrobial Drug Discovery
CO-ADD is an open-access crowd sourcing initiative created to help researchers uncover new antibiotics, by providing free, unencumbered testing for activity against pathogenic bacteria and fungi/yeast. CO-AD includes SPARK, a community knowledge base.
CO-ADD and SPARK, the Shared Platform for Antibiotic Research and Knowledge, provide a platform to share expertise, results, & predictive models.
- Microbial diagnostics
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
- Infection prevention
- Antimicrobial stewardship
- Market entry
- Marketed product
- Joint Venture
- OTHER / NA
Infectious disease area:
- North America
- South America
The Centre for Superbug Solutions is focused on therapeutic and diagnostic solutions to AMR. Based within IMB at UQ, it includes CO-ADD & SPARK.
1) OPX & OPX-P: lipopeptides for XDR G-ve strains, CARB-X funded. 2) Vancapticin: preclinical lipoglycopeptide. 3) Bicyclic nitroimidazole: MTb+parasites. 4) Toolset of antibiotic-derived fluoro probes. 5) Bacterial capture magnetic nanoparticles.